RO8191

RO8191 is an agonist of STAT and JAK used in studies of JAK-STAT Signaling. It is especially relevant in cancer, cell signaling, and immunology models, where defined compound exposure can be linked to cytokine-responsive transcriptional signaling and immune regulation.

By activating STAT and JAK, RO8191 can be used to examine cytokine-responsive transcriptional signaling and immune regulation. The signaling pathway modulator annotation adds relevance to pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving STAT and JAK
• Pathway perturbation studies connected to JAK-STAT Signaling
• Agonist-response and downstream signaling studies
• Pathway-reporter and mechanistic-phenotyping studies

Overall, RO8191 is appropriate when a defined chemical perturbant is needed to connect STAT and JAK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.